Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired

Total Raised


About ZS Genetics

ZS Genetics is developing a technology platform for directly creating detailed images of individual DNA or RNA molecules. ZS Genetics' Third Generation process adapts existing technologies to new applications.

ZS Genetics Headquarters Location

9 Audubon Road

Wakefield, Massachusetts, 01880,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ZS Genetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ZS Genetics is included in 3 Expert Collections, including Medical Devices.


Medical Devices

8,483 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,406 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

7,901 items

Latest ZS Genetics News

Seven Bridges, ZS Genetics Partner for Multiomics Analytics in Drug Development

May 7, 2021

Save for later NEW YORK – Seven Bridges Genomics said this week that it is partnering with biomedical research services firm ZS Genetics to provide scalable multiomics analytics for drug development. Seven Bridges Chief Revenue Officer Bruce Press said that his company will be integrating its core multiomics analysis platform as well as its Aria technology for analyzing genotypic and phenotypic data for drug discovery with ZS's store of research data to help the latter company better serve its pharmaceutical customers. Boston-based Seven Bridges said in a statement that this combination will provide a "one-stop solution for innovation and scalability." ZS, of Wakefield, Massachusetts, has built up a large data warehouse over the last several years. "Working side by side with our clients to help streamline R&D data and increase speed to market to improve patients' lives is at the core of what we do," ZS research and development leader Aaron Mitchell said in a statement. "Our partnership with Seven Bridges provides our clients, and ultimately patients, a faster path to new treatments and diagnostics." John Piccone, who heads the biomedical research service line for ZS, said genomic and molecular-level analysis are essential for drug discovery, translational medicine, and preclinical drug development today. "Our partnership with Seven Bridges gives our clients a new option for innovation and scalable capacity," Piccone said. "The combination of Seven Bridges platform and experts with ZS consulting teams provides a scalable solution for clients with growing multiomics data and analytics needs."

  • Where is ZS Genetics's headquarters?

    ZS Genetics's headquarters is located at 9 Audubon Road, Wakefield.

  • What is ZS Genetics's latest funding round?

    ZS Genetics's latest funding round is Acquired.

  • How much did ZS Genetics raise?

    ZS Genetics raised a total of $9.23M.

  • Who are the investors of ZS Genetics?

    Investors of ZS Genetics include Genetics Research and Northeast Angels.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.